Mechanism of Action of Semaglutide (Ozempic/Wegovy)
Introduction Semaglutide (Ozempic for diabetes; Wegovy for obesity) is a GLP‑1 receptor agonist used for type 2 diabetes mellitus management and chronic weight loss. It mimics the incretin hormone glucagon‑like peptide‑1 (GLP‑1), leading to improved glycemic control, reduced appetite, delayed gastric emptying, and favorable effects on cardiovascular risk. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value … Read more